DalsnaFinance › IPOs › Xilio Therapeutics › IPO
Xilio Therapeutics, Inc. completed its initial public offering on NASDAQ on October 22, 2021, pricing at $16.00 a share.
| Ticker | XLO |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 22, 2021 |
| Offering price | $16.00 |
| Shares offered | 7,353,000 |
| Total raised | $118M |
Xilio Therapeutics, Inc. sold 7,353,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $117.6 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $118 million total recorded for the deal.
Xilio Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Xilio Therapeutics, Inc.. This page is general information, not investment advice.